학술논문
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
Document Type
Journal
Author
Holloway, Robert W.; Thaker, Premal; Mendivil, Alberto A.; Ahmad, Sarfraz; Al-Niaimi, Ahmed N.; Barter, James; Beck, Tiffany; Chambers, Setsuko K.; Coleman, Robert L.; Crafton, Sarah M.; Crane, Erin; Ramez, Eskander; Ghamande, Sharad; Graybill, Whitney; Herzog, Thomas; Indermaur, Megan Dr; John, Veena S.; Landrum, Lisa; Lim, Peter C.; Lucci, Joseph A.; McHale, Michael; Monk, Bradley J.; Moore, Kathleen Nadine; Morris, Robert; O'Malley, David M.; Reid, Thomas J.; Richardson, Debra; Rose, Peter G.; Scalici, Jennifer M.; Silasi, Dan-Arin; Tewari, Krishnansu; Wang, Edward W.
Source
Subject
Language
English
ISSN
15251438